Kristen L. Shirar

Learn More
PURPOSE Thymoma represents one of the rarest of all malignancies. Stage and completeness of resection have been used to ascertain postoperative therapeutic strategies albeit with limited prognostic accuracy. A molecular classifier would be useful to improve the assessment of metastatic behaviour and optimize patient management. METHODS qRT-PCR assay for(More)
68 Background: Therapeutic decisions for patients with thymomas are made on tumor stage as histologic classification is of limited prognostic value. A molecular prognostic tool may better predict the likelihood of metastasis in thymomas and enable better management of patients. METHODS Reverse-transcriptase-polymerase-chain-reaction (RT-PCR) assay for 23(More)
  • 1